Is NSE truly a useful marker in NSCLC?

Lung Cancer. 2004 May;44(2):267; author reply 269. doi: 10.1016/j.lungcan.2003.11.001.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Biomarkers, Tumor / analysis*
  • Carcinoma, Non-Small-Cell Lung / pathology*
  • Humans
  • Lung Neoplasms / pathology*
  • Phosphopyruvate Hydratase / analysis*
  • Prognosis
  • Reproducibility of Results
  • Survival Analysis

Substances

  • Biomarkers, Tumor
  • Phosphopyruvate Hydratase